Effects of aminoguanidine administration on vascular hyporeactivity in thoracic aorta from endotoxaemic rats

被引:12
作者
Erol, A [1 ]
Kosay, S [1 ]
机构
[1] Ege Univ, Fac Med, Dept Pharmacol, TR-35100 Izmir, Turkey
关键词
endotoxic shock; aminoguanidine; nitric oxide (NO); (Rat);
D O I
10.1016/S0014-2999(00)00764-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Overproduction of nitric oxide has been implicated in the pathogenesis of the vascular hyporesponsiveness of endotoxic shock. In this study, we investigated the effects of aminoguanidine, an inducible nitric oxide synthase inhibitor, on the decreased vascular responsive ness in endotoxic shock. Male albino rats were administered intraperitoneally aminoguanidine (25, 50 or 75 mg kg(-1)) 1 h after they received saline or lipolysaccharide (Escherichia coli serotype 055:B5). The thoracic aortas were removed 18 h after Lipopolysaccharide administration and suspended in organ baths containing Krebs solution, and tested for vascular reactivity. Contractile responses to phenylephrine and potassium chloride, and relaxant responses to acetylcholine were reduced in endotoxaemic animals. Aminoguanidine was ineffective in improving the vascular hypocontractility at 25 and 75 mg kg(-1) doses; but at 50 mg kg(-1) dose, it restored the decreased contractile responses toward normal values. Diminished relaxant responses to acetylcholine were restored by aminoguanidine at all three different doses. There were no significant differences in sodium nitroprusside induced relaxant responses between all groups. Administration of aminoguanidine in control animals did not change vascular responses to any agent. These data suggest that aminoguanidine treatment improves the vascular hyporesponsiveness to contractile- and endothelium-dependent relaxant agents observed in endotoxic shock. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 46 条
  • [1] Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia
    Arkovitz, MS
    Wispe, JR
    Garcia, VF
    Szabo, C
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1996, 31 (08) : 1009 - 1015
  • [2] FEEDBACK INHIBITION OF NITRIC-OXIDE SYNTHASE ACTIVITY BY NITRIC-OXIDE
    ASSREUY, J
    CUNHA, FQ
    LIEW, FY
    MONCADA, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) : 833 - 837
  • [3] INTERLEUKIN-1 AND ENDOTOXIN ACTIVATE SOLUBLE GUANYLATE-CYCLASE IN VASCULAR SMOOTH-MUSCLE
    BEASLEY, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (01): : R38 - R44
  • [4] ENDOTOXIN INHIBITS CONTRACTION OF VASCULAR SMOOTH-MUSCLE INVITRO
    BEASLEY, D
    COHEN, RA
    LEVINSKY, NG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (04): : H1187 - H1192
  • [5] ENDOTOXIN-INDUCED IMPAIRMENT OF VASCULAR SMOOTH-MUSCLE CONTRACTIONS ELICITED BY DIFFERENT MECHANISMS
    BIGAUD, M
    JULOUSCHAEFFER, G
    PARRATT, JR
    STOCLET, JC
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 190 (1-2) : 185 - 192
  • [6] RELATIONSHIP BETWEEN PAF-ACETHER AND THROMBOXANE-A2 BIOSYNTHESIS IN ENDOTOXIN-INDUCED INTESTINAL DAMAGE IN THE RAT
    BOUGHTONSMITH, NK
    HUTCHESON, I
    WHITTLE, BJR
    [J]. PROSTAGLANDINS, 1989, 38 (03): : 319 - 333
  • [7] NEGATIVE FEEDBACK-REGULATION OF ENDOTHELIAL-CELL FUNCTION BY NITRIC-OXIDE
    BUGA, GM
    GRISCAVAGE, JM
    ROGERS, NE
    IGNARRO, LJ
    [J]. CIRCULATION RESEARCH, 1993, 73 (05) : 808 - 812
  • [8] Effects of MK-886, a leukotriene biosynthesis inhibitor, in a rabbit model of endotoxic shock
    Can, C
    Çinar, MG
    Ülker, S
    Evinç, A
    Kosay, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (2-3) : 223 - 228
  • [9] AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION
    CORBETT, JA
    TILTON, RG
    CHANG, K
    HASAN, KS
    IDO, Y
    WANG, JL
    SWEETLAND, MA
    LANCASTER, JR
    WILLIAMSON, JR
    MCDANIEL, ML
    [J]. DIABETES, 1992, 41 (04) : 552 - 556
  • [10] MECHANISTIC STUDIES OF ADVANCED GLYCOSYLATION END-PRODUCT INHIBITION BY AMINOGUANIDINE
    EDELSTEIN, D
    BROWNLEE, M
    [J]. DIABETES, 1992, 41 (01) : 26 - 29